Lumos Pharma News

Lumos Pharma | 10-K/A: Annual report (Amendment)

Apr 22 16:32 ET

Lumos Pharma | 8-K: Current report

Apr 18 16:57 ET

Lumos Pharma | ARS: Annual Report to Security Holders

Apr 15 16:35 ET

Lumos Pharma | DEFA14A: Others

Apr 12 17:29 ET

Lumos Pharma | DEF 14A: Definitive information statements

Apr 12 17:04 ET

Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Schuchart Aaron

Apr 3 17:16 ET

Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Hawkins Richard J

Apr 3 17:16 ET

Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer McKew John C.

Apr 3 17:16 ET

Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer POWERS BRADLEY J

Apr 3 17:15 ET

Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Lawley Lori D

Apr 3 17:14 ET

Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Pitukcheewanont Pisit Duke

Apr 3 17:13 ET

Lumos Pharma | 8-K: Current report

Mar 20 16:29 ET

Lumos Pharma | 10-K: Annual report

Mar 7 16:51 ET

Lumos Pharma | 8-K: Current report

Mar 7 16:46 ET

Lumos Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-THE GOLDMAN SACHS GROUP, INC.(5.1 %),GOLDMAN SACHS & CO. LLC(5.1 %)

Feb 9 19:15 ET

Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer McKew John C.

Feb 7 17:27 ET

Lumos Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 6 16:03 ET

Lumos Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Wells Fargo & Company (b) Tax ID(5.3%)

Feb 6 10:02 ET

Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer McKew John C.

Feb 5 17:59 ET

Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Hawkins Richard J

Feb 5 17:58 ET